BRAF and melanoma: It will be interesting to determine whether this loop and the signaling bypass created by BRAF-dependent PAX3 phosphorylation is also operative in other tissues and in cancer cells such as rhabdomyosarcoma and melanoma cells, which would offer new refined therapeutic approaches.